Revenues increased to RMB2.04 billion,representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million,from an adjusted net loss of RMB17.4 million in the same period of 2023
08-29
Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS,and is also the only study to achieve the primary e
08-29
SHENZHEN,China,Aug. 28,2024-- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company")has officially announced the signing of a non-disclosure agreement (the "NDA") with Bow
08-29
The initiative provides opportunities forBabilou Family Singapore\'s early childhood educators to share best practices,equipping them with global insights.
08-29
LIMASSOL,Cyprus,Aug. 29,2024--Doo Prime successfully concluded a premier partner event held at the renowned Old Trafford Stadium on Saturday,August 10,2024. As one of the most significant gatherings
08-29
HONG KONG,Aug. 27,2024-- On August 22,AAC Technologies (02018.HK) held its 2024 interim results presentation in Hong Kong,delivering remarkably impressive performance.
08-28
INDIANAPOLIS and PARIS,Aug. 27,2024-- Stamus Networks,a global provider of high-performance network-based threat detection and response (NDR) systems,today announced it has been named a Sample Vendor
08-28
BRADENTON,Fla.,Aug. 27,2024-- BAIYU Holdings,Inc. ("BAIYU" or the "Company") (Nasdaq: BYU),a leading B2B bulk commodity e-commerce platform and supply chain service provider,today
08-28
PISCATAWAY,N.J.,Aug. 27,2024-- Legend Biotech (NASDAQ: LEGN),a subsidiary of GenScript Biotech Corporation (hereinafter referred to as "GenScript"),a global leader in life sciences research
08-28
BEIJING,Aug. 28,2024-- Jenscare Scientific Co.,Ltd. ("Jenscare" or the "Company") (HKEX: 9877),an innovative medical device company dedicated to interventional treatment for struct
08-28
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map
